Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | DUSP3 | P51452 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | DGKA | P23743 | 1/20 | 0.82 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | FAAH | O00519 | 2/20 | 0.68 |
| ▸ | PRKCA | P17252 | 3/20 | 0.66 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.66 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.66 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.66 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.65 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.65 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.65 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.65 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.65 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.65 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL526047 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Monoctanoin Component B SCHEMBL22366087 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glycerol Monolaurate SCHEMBL16042 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL595035 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21685815 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21685794 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Octane SCHEMBL5181039 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL3503441 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL5719482 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL16538137 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | ROCHAL TECHNOLOGIES LLC (US) | 2023-12-12 | — | — | US | claimed |
| WO-2023160458-A1 | CHINESE HERBAL MEDICINE ACTIVE SUBSTANCE @ VESICLE COMPLEX HAVING HAIR CARE AND GROWTH EFFECTS, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 山东大学 | 2023-08-31 | — | — | WO | claimed |
| EP-4051239-A1 | POLOXAMER COMPOSITIONS WITH REDUCED SOL-GEL TRANSITION TEMPERATURES AND METHODS OF REDUCING THE SOL-GEL TRANSITION TEMPERATURE OF POLOXAMER COMPOSITIONS | Rochal Technologies LLC (US) | 2022-09-07 | — | — | EP | claimed |
| CN-114929200-A | Method for lowering sol-gel transition temperature | 罗查尔科技有限责任公司 | 2022-08-19 | — | — | CN | claimed |
| WO-2021086698-A1 | METHODS FOR REDUCING THE TEMPERATURE OF SOL-GEL TRANSITIONS | ROCHAL INDUSTRIES, LLC (US) | 2021-05-06 | — | — | WO | claimed |
| US-20210121575-A1 | Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions | ROCHAL INDUSTRIES, LLC (US) | 2021-04-29 | — | — | US | claimed |
| EP-2787985-B1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2020-07-01 | — | — | EP | claimed |
| US-20190262268-A1 | ORAL MODIFIED RELEASE FORMULATIONS | RUBICON RES PRIVATE LIMITED (IN) | 2019-08-29 | — | — | US | claimed |
| WO-2018055641-A1 | ORAL MODIFIED RELEASE FORMULATIONS | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2018-03-29 | — | — | WO | claimed |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | ROCHAL INDUSTRIES, LLC (US) | 2017-12-21 | — | — | US | claimed |
| US-8829053-B2 | Biocidal compositions and methods of using the same | ROCHAL INDUSTRIES LLP (US) | 2014-09-09 | — | — | US | claimed |
| US-20130309282-A1 | HAIRSTYLING AGENT COMPOSITION | KIKUBOSHI CORPORATION (JP) | 2013-11-21 | — | — | US | claimed |
| US-20130150451-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLP (US) | 2013-06-13 | — | — | US | claimed |
| WO-2013086181-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLP (US) | 2013-06-13 | — | — | WO | claimed |
| WO-2007070561-A2 | AGENTS FOR CONTROLLING BIOLOGICAL FLUIDS AND METHODS OF USE THEREOF | SOUTHEASTERN MEDICAL TECHNOLOGIES (US) | 2007-06-21 | — | — | WO | claimed |
| WO-2007046577-A1 | EXTERNAL COMPOSITION FOR HAIR GROWTH | AMOREPACIFIC CORPORATION (KR) | 2007-04-26 | — | — | WO | claimed |
| US-20070059350-A1 | Agents for controlling biological fluids and methods of use thereof | SOUTHEASTERN MEDICAL TECHNOLOGIES, LLC | 2007-03-15 | — | — | US | claimed |
| US-20070053957-A1 | Agents for controlling biological fluids and methods of use thereof | SOUTHEASTERN MEDICAL TECHNOLOGIES, LLC | 2007-03-08 | — | — | US | claimed |
| EP-0397211-B1 | PERCUTANEOUS ADMINISTRATION OF 3'-AZIDE-3'-DEOXYTHYMIDINE | NELSON-SUMISHO Co., Ltd. (JP) | 1993-05-12 | — | — | EP | claimed |
| EP-0397211-A2 | Percutaneous administration of 3'-azide-3'-deoxythymidine | NELSON-SUMISHO Co., Ltd. (JP) | 1990-11-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | CUTA, MMP8, MMP1 | LMNA 1237/4885KDM4E 4848/4885DUSP3 1252/4885 |
| US-20210121575-A1 | Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions | PAOX, HPGDS, SPTSSB | LMNA 2898/4885KDM4E 4814/4885DUSP3 1255/4885 |
| US-20130150451-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | GCG, BID, DGAT1 | LMNA 4213/4885KDM4E 3836/4885DUSP3 141/4885 |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | CUTA, MMP8, MMP1 | LMNA 1237/4885KDM4E 4848/4885DUSP3 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.